Skip to main content
Equibles

Chase LoPriore

Board Member

Hepion Pharmaceuticals, Inc. (HEPA)

Equibles does not estimate personal net worth.

Get an email with a short summary when Hepion Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get HEPA alerts

About Chase LoPriore

Chase LoPriore is recorded as Board Member at Hepion Pharmaceuticals, Inc. (HEPA) since March 16, 2026. Hepion Pharmaceuticals, Inc. reported in an 8-K filed March 18, 2026 that Chase LoPriore was appointed director, effective March 16, 2026. Hepion Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Hepion Pharmaceuticals, Inc. includes Dr. Kaouthar Lbiati (CEO), Gary Stetz (CEO, CFO and Board Member), John Cavan (CEO and CFO) and 7 others.

“On March 16, 2026, the Board approved the appointment of Gary Stetz as interim Chief Executive Officer of the Company and director and appointed Vincent LoPriore as Executive Chairman, Sireesh Appajosyula as director and Chase LoPriore as director.”
Hepion Pharmaceuticals, Inc. Form 8-K, filed March 18, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Hepion Pharmaceuticals, Inc.

Recent activity